These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 3953353)

  • 21. Use of intravenous amiodarone for emergency treatment of life-threatening ventricular arrhythmias.
    Helmy I; Herre JM; Gee G; Sharkey H; Malone P; Sauve MJ; Griffin JC; Scheinman MM
    J Am Coll Cardiol; 1988 Oct; 12(4):1015-22. PubMed ID: 3417974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of sudden recurrent arrhythmic deaths: role of amiodarone.
    Nademanee K; Singh BN; Cannom DS; Weiss J; Feld G; Stevenson WG
    Am Heart J; 1983 Oct; 106(4 Pt 2):895-901. PubMed ID: 6613836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined mexiletine and amiodarone treatment of refractory recurrent ventricular tachycardia.
    Waleffe A; Mary-Rabine L; Legrand V; Demoulin JC; Kulbertus HE
    Am Heart J; 1980 Dec; 100(6 Pt 1):788-93. PubMed ID: 7446381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amiodarone: intravenous loading for rapid suppression of complex ventricular arrhythmias.
    Mostow ND; Rakita L; Vrobel TR; Noon D; Blumer J
    J Am Coll Cardiol; 1984 Jul; 4(1):97-104. PubMed ID: 6736461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias.
    Greene HL; Graham EL; Werner JA; Sears GK; Gross BW; Gorham JP; Kudenchuk PJ; Trobaugh GB
    J Am Coll Cardiol; 1983 Dec; 2(6):1114-28. PubMed ID: 6685151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis.
    Chiale PA; Halpern MS; Nau GJ; Tambussi AM; Przybylski J; Lázzari JO; Elizari MV; Rosenbaum MB
    Am Heart J; 1984 Apr; 107(4):656-65. PubMed ID: 6702559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerance of high-dose intravenous amiodarone for recurrent, refractory ventricular tachycardia.
    Mooss AN; Mohiuddin SM; Hee TT; Esterbrooks DJ; Hilleman DE; Rovang KS; Sketch MH
    Am J Cardiol; 1990 Mar; 65(9):609-14. PubMed ID: 2178383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic effects of intravenous administration of amiodarone in congestive heart failure from chronic Chagas' disease.
    Bellotti G; Silva LA; Esteves Filho A; Rati M; de Moraes AV; Ramires JA; da Luz P; Pileggi F
    Am J Cardiol; 1983 Nov; 52(8):1046-9. PubMed ID: 6637821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antiarrhythmic effect and side effects of amiodarone].
    Weber H; Weissel M; Haddad R; Scheibelhofer W; Konrad K; Mlczoch J; Probst P; Mainitz M
    Wien Klin Wochenschr; 1984 Sep; 96(18):685-96. PubMed ID: 6523885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of amiodarone during long-term treatment of potentially dangerous ventricular arrhythmias in patients with chronic stable ischemic heart disease.
    Kaski JC; Girotti LA; Elizari MV; Lázzari JO; Goldbarg A; Tambussi A; Rosenbaum MB
    Am Heart J; 1984 Apr; 107(4):648-55. PubMed ID: 6702558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias.
    Primeau R; Agha A; Giorgi C; Shenasa M; Nadeau R
    Can J Cardiol; 1989 Mar; 5(2):98-104. PubMed ID: 2706579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amiodarone: a unique antiarrhythmic agent.
    Sloskey GE
    Clin Pharm; 1983; 2(4):330-40. PubMed ID: 6349912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous amiodarone in the acute termination of supraventricular arrhythmias.
    Holt P; Crick JC; Davies DW; Curry P
    Int J Cardiol; 1985 May; 8(1):67-79. PubMed ID: 3997293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study.
    Hohnloser SH; Meinertz T; Dammbacher T; Steiert K; Jähnchen E; Zehender M; Fraedrich G; Just H
    Am Heart J; 1991 Jan; 121(1 Pt 1):89-95. PubMed ID: 1985383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic effects of intravenous amiodarone in patients with depressed left ventricular function and recurrent ventricular tachycardia.
    Schwartz A; Shen E; Morady F; Gillespie K; Scheinman M; Chatterjee K
    Am Heart J; 1983 Oct; 106(4 Pt 2):848-56. PubMed ID: 6613831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness.
    Flaker GC; Alpert MA; Webel RR; Ruder MA; Sanfelippo JF; Tsutakawa RK
    Am Heart J; 1985 Aug; 110(2):371-6. PubMed ID: 4025112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid suppression of complex ventricular arrhythmias with high-dose oral amiodarone.
    Mostow ND; Vrobel TR; Noon D; Rakita L
    Circulation; 1986 Jun; 73(6):1231-8. PubMed ID: 3698254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognosis after sudden cardiac death without associated myocardial infarction: one year follow-up of empiric therapy with amiodarone.
    Peter T; Hamer A; Weiss D; Mandel WJ
    Am Heart J; 1984 Feb; 107(2):209-13. PubMed ID: 6695654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ventricular arrhythmias: use of electrophysiologic studies.
    Horowitz LN; Spielman SR; Greenspan AM; Webb CR; Kay HR
    Am Heart J; 1983 Oct; 106(4 Pt 2):881-6. PubMed ID: 6613834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.